Sigma-Aldrich Report issue

For profit Phase 1
Founded: St Louis MO United States (1975)
Status: Acquired by Merck KGaA (2014) → now Merck Serono (2006)

Organization Overview

First Clinical Trial
2017
NCT04540107
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Sigma-Aldrich